Sleep Apnea

The Healio Editors compiled the most-read news in pulmonology posted in July.

CHARLOTTE, N.C. — Study participants with a history of migraine experienced less sleep apnea and hypoxia than those without migraine, according to a poster presented at the SLEEP meeting.

Most patients with obstructive sleep apnea retained their metabolic syndrome diagnosis after CPAP therapy, despite higher rates of reversibility after treatment, according to findings of a randomized trial published in Chest.

A new study demonstrated that obstructive sleep apnea has an acute effect on biomarkers for Alzheimer’s disease and the ability to measure such biomarkers from blood.

Low levels of serum estrogen and progesterone in middle-aged women were linked to a higher risk for obstructive sleep apnea symptoms, according to a population-based study published in PLOS ONE.

CHARLOTTE, N.C. — The link between sleep apnea and cardiovascular disease involves multiple pathways and outcomes, Susan Redline, MD, MPH, Peter C. Farrell Professor of Sleep Medicine at Harvard Medical School, said at SLEEP 2022.

In a recent study, researchers found no between-group differences in myocardial infarction, stroke or cardiovascular death among patients with prediabetes who received metformin, a lifestyle intervention or placebo.

Patients with CVD are 40% to 80% more likely to have comorbid obstructive sleep apnea, which in severe cases can cause them to stop breathing hundreds of times a night.

A recent study found that time-restricted eating was associated with a reduced risk for CVD among older women with overweight who received cardiotoxic breast cancer treatment.

Patients with HF who received an implantable cardioverter defibrillator that detected severe sleep apnea may be two- to threefold more likely to experience an atrial fibrillation episode, according to a new analysis of DASAP-HF data.